This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Persistent postconcussion symptoms (PPS) and depression

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Persistent Postconcussion Symptoms and depression

The rate of concussion (or mild traumatic brain injury recovery can vary considerably from one individual to another

  • vast majority fully recover within days to weeks following the injury
  • a minority (ie, 15%-30%) of individuals who experienced a concussion will experience symptoms for months or years following the injury, often referred to as persistent postconcussion symptoms (PPCS)
    • symptoms commonly reported include headaches, fatigue, dizziness, cognitive difficulties, and emotional changes and can significantly impact an individual's everyday functioning

A systematic review and meta-analysis of 18 studies and 9101 participants found that the odds of depressive symptoms were increased 4-fold among individuals who experienced persistent postconcussion symptoms [PPCS]:

  • findings suggest that individuals with PPCS are at risk of experiencing symptoms of depression; postinjury support and interventions targeting mental health are necessary for optimal outcomes (1)

Reference:

  • Lambert M, Sheldrake E, Deneault A, Wheeler A, Burke M, Scratch S. Depressive Symptoms in Individuals With Persistent Postconcussion Symptoms: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2022;5(12):e2248453. doi:10.1001/jamanetworkopen.2022.48453

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.